In brief, N-terminal HA-peptide (YPYDVPDYA)-tagged FUS/TLS was amplified by PCR and inserted into pcDNA5/TO/FRT/LAP using XhoI and NotI sites
The more common adverse effects include allergic reactions, stomach pain, diarrhea, constipation, nausea, and vomiting
cite Oral semaglutide (Rybelsus) was developed for diabetes and can affect weight, but its dosing and FDA-approved indication differ from injectable weight-loss products
Observed responses in research settings are generally mild and may include temporary administration-site irritation, redness, warmth sensations, local sensitivity, temporary itching, mild fatigue, or response variability depending on research amount, administration frequency, protocol duration, and individual sensitivity
Always consult a professional for guidance, ensure all ingredients are pharmaceutical-grade, maintain strict hygiene, and measure accurately
Q3: How much weight loss did CagriSema produce in REDEFINE 1
